1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsHIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) is sponsored by National Institutes of Health. Supports research on HIV-associated non-communicable diseases at LMIC institutions to enhance research capacity and build networks addressing this critical burden.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
HIV-associated Noncommunicable Diseases Research at LMIC Institutions (R21) - Fogarty International Center @ NIH NIH Websites Are Changing Get the Latest Updates and FAQs HIV-associated Noncommunicable Diseases Research at Low- and Middle-Income Country Institutions HIV-associated Noncommunicable Diseases Research at Low- and Middle-Income Country Institutions aims to support locally relevant research in critical areas of HIV-associated noncommunicable diseases at LMIC institutions, to enhance research capacity and build a network of researchers both within and across LMICs to address this critical burden.
This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH).
This includes exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS research priorities .
Research teams should contain an appropriate mix of expertise to accomplish the proposed studies, including partnerships between HIV and NCD researchers who can initiate new ideas and determine feasibility of novel approaches to understand and reduce the long-term suffering from the comorbid disorders.
Applicants will also be asked to address the needs of collaborating LMIC institutions to develop capacity for carrying out research in this field. LMICs are defined by The World Bank as low-, lower-middle-, or upper-middle-income economies . See full Eligibility Information in the funding announcement for more details.
View a full list of HIV-associated NCDs Research awards Division of International Training and Research Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Bethesda, MD 20892-2220 USA The announcements related to this program are issued by Fogarty in collaboration with the following NIH Institutes, Centers and Offices: National Cancer Institute (NCI) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute of Mental Health (NIMH) Profiling the lung microbiome to fight COPD in Uganda Global Health Matters, July/August 2023 Research to guide practice: Enhancing HIV/AIDS platforms to address NCDs in sub-Saharan Africa Workshop: HIV-associated Comorbidities, Co-infections and Complications Recorded webcast Day 1 - Sep 19, 2019 Recorded webcast Day 2 - Sep 20, 2019 HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) (PAR-21-246) expired December 9, 2022 Grants awarded through PAR-21-246 via NIH RePORTER HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) (PAR-20-030) expired December 4, 2020 Grants awarded through PAR-20-030 via NIH RePORTER Related Global Health Research Topics
According to the current listing, eligibility includes: Universities in Low- and Middle-Income Countries (LMICs). Confirm the full requirements in the official notice before applying.
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) is funded by National Institutes of Health. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article